chr19-56414048-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152478.3(ZNF583):āc.99A>Cā(p.Lys33Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000264 in 1,607,510 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152478.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF583 | NM_152478.3 | c.99A>C | p.Lys33Asn | missense_variant | 3/5 | ENST00000333201.13 | NP_689691.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF583 | ENST00000333201.13 | c.99A>C | p.Lys33Asn | missense_variant | 3/5 | 2 | NM_152478.3 | ENSP00000388502 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000165 AC: 40AN: 242552Hom.: 0 AF XY: 0.000183 AC XY: 24AN XY: 131156
GnomAD4 exome AF: 0.000274 AC: 399AN: 1455286Hom.: 0 Cov.: 31 AF XY: 0.000256 AC XY: 185AN XY: 723954
GnomAD4 genome AF: 0.000171 AC: 26AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.99A>C (p.K33N) alteration is located in exon 3 (coding exon 2) of the ZNF583 gene. This alteration results from a A to C substitution at nucleotide position 99, causing the lysine (K) at amino acid position 33 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at